Ryman Healthcare Valuation
| RH7 Stock | EUR 2.49 0.01 0.40% |
Based on Macroaxis valuation methodology, the company appears to be overvalued. Ryman Healthcare holds a recent Real Value of €2.18 per share. The prevailing price of the company is €2.49. Our model determines the value of Ryman Healthcare from analyzing the company fundamentals such as Shares Outstanding of 530.46 M, return on equity of 0.18, and Operating Margin of (0.02) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Ryman Healthcare's price fluctuation is relatively risky at this time. Calculation of the real value of Ryman Healthcare is based on 3 months time horizon. Increasing Ryman Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Ryman stock is determined by what a typical buyer is willing to pay for full or partial control of Ryman Healthcare Limited. Since Ryman Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ryman Stock. However, Ryman Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.49 | Real 2.18 | Hype 2.49 |
The real value of Ryman Stock, also known as its intrinsic value, is the underlying worth of Ryman Healthcare Company, which is reflected in its stock price. It is based on Ryman Healthcare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ryman Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ryman Healthcare Limited helps investors to forecast how Ryman stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ryman Healthcare more accurately as focusing exclusively on Ryman Healthcare's fundamentals will not take into account other important factors: Ryman Healthcare Total Value Analysis
Ryman Healthcare Limited is at this time estimated to have takeover price of 3.82 B with market capitalization of 1.99 B, debt of 2.58 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ryman Healthcare fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.82 B | 1.99 B | 2.58 B |
Ryman Healthcare Investor Information
About 17.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.93. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Ryman Healthcare has Price/Earnings To Growth (PEG) ratio of 2.57. The entity last dividend was issued on the 8th of December 2022. Based on the measurements of operating efficiency obtained from Ryman Healthcare's historical financial statements, Ryman Healthcare Limited is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Ryman Healthcare Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Ryman implies not a very effective usage of assets in January.Ryman Healthcare Ownership Allocation
Ryman Healthcare owns a total of 530.46 Million outstanding shares. Ryman Healthcare holds 11.54 pct. of its outstanding shares held by insiders and 16.69 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Ryman Healthcare Profitability Analysis
The company reported the revenue of 503.76 M. Net Income was 692.87 M with profit before overhead, payroll, taxes, and interest of 42.52 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ryman Healthcare's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ryman Healthcare and how it compares across the competition.
About Ryman Healthcare Valuation
The stock valuation mechanism determines Ryman Healthcare's current worth on a weekly basis. Our valuation model uses a comparative analysis of Ryman Healthcare. We calculate exposure to Ryman Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ryman Healthcare's related companies.Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company was founded in 1984 and is based in Christchurch, New Zealand. RYMAN HEALTHCARE operates under Long-Term Care Facilities classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5300 people.
8 Steps to conduct Ryman Healthcare's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ryman Healthcare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ryman Healthcare's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ryman Healthcare's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ryman Healthcare's revenue streams: Identify Ryman Healthcare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ryman Healthcare's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ryman Healthcare's growth potential: Evaluate Ryman Healthcare's management, business model, and growth potential.
- Determine Ryman Healthcare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ryman Healthcare's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Ryman Stock analysis
When running Ryman Healthcare's price analysis, check to measure Ryman Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryman Healthcare is operating at the current time. Most of Ryman Healthcare's value examination focuses on studying past and present price action to predict the probability of Ryman Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryman Healthcare's price. Additionally, you may evaluate how the addition of Ryman Healthcare to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |